Government medicines patient Coronavirus

Who can make Gilead's coronavirus drug, licence free?

Reading now: 456
www.livemint.com

Gilead Sciences Inc is in talks with chemical and drug makers to produce its experimental drug remdesivir, a potential coronavirus treatment, for Europe, Asia and the developing world, the firm has said.

Its patent gives the U.S. company exclusive rights to make the antiviral. But international trade rules allow nations defined by the United Nations as least-developed countries (LDCs) to ignore the patent and make drugs such as remdesivir more affordable in their markets.

Here is how production and distribution of remdesivir would work in less developed countries, under World Trade Organisation (WTO) rules. WHICH ARE THE LEAST DEVELOPED COUNTRIES? Of the 47 countries in this U.N.

Read more on livemint.com
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

DMCA